Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug toxicity: Drug–Drug Interaction

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Pharmacokinetics: Drug–Drug Interactions

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

Combined Effects of Drugs: Antagonism

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Volumetric absorptive microsampling for lumateperone analysis: method validation and stability evaluation.

Analytical and bioanalytical chemistry·2025

Same author

Exposure of dams to Elexacaftor/ Tezacaftor/Ivacaftor during pregnancy and breastfeeding induces reversible alterations in newborn wild type CD-1 mice.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025

Same author

How microsampling is impacting pharmacokinetic and toxicokinetic studies: volumetric absorptive microsampling (VAMS).

Bioanalysis·2025

Same author

Vaginal <i>Lactobacillus gasseri</i> biosurfactant: a novel bio- and eco-compatible anti-<i>Candida</i> agent.

Biofilm·2025

Same author

Review: the role of automation in improving the performance and throughput of microsample bioanalysis.

Analytica chimica acta·2025

Same author

Development of an accelerated ageing protocol for the study of phytocannabinoid stability in Cannabis sativa L.

Journal of pharmaceutical and biomedical analysis·2024

Search research articles

Related Experiment Video

Updated: Jul 18, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

Possible levomepromazine-clozapine interaction: two case reports.

Francesca Bugamelli¹, Roberto Mandrioli, Ernst Kenndler

¹Department of Pharmaceutical Sciences, Faculty of Pharmacy, Alma Mater Studiorum--University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy.

Progress in Neuro-Psychopharmacology & Biological Psychiatry

|December 19, 2006

Summary

This study suggests a potential drug interaction between levomepromazine (LMP) and clozapine (CLZ). Concomitant use may lead to low clozapine levels and reduced treatment effectiveness.

Related Experiment Videos

Last Updated: Jul 18, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

Area of Science:

Pharmacology
Psychiatry

Background:

Investigating potential drug interactions between antipsychotics is crucial for optimizing patient outcomes.
Levomepromazine (LMP) is a classical neuroleptic, while clozapine (CLZ) is an atypical antipsychotic with a distinct pharmacological profile.

Observation:

Two patients on concurrent levomepromazine and clozapine therapy exhibited unexpectedly low plasma clozapine levels despite high dosages.
These patients were classified as non-responders to clozapine treatment.
Upon discontinuation of levomepromazine, clozapine plasma concentrations normalized, and one patient showed a therapeutic response.

Findings:

The co-administration of levomepromazine may significantly reduce plasma concentrations of clozapine.
This interaction could lead to a lack of therapeutic efficacy in patients treated with both medications.
Literature review revealed no prior reports on levomepromazine and clozapine interactions.

Implications:

Clinicians should consider a potential pharmacokinetic interaction when levomepromazine is prescribed with clozapine.
Monitoring clozapine plasma levels and therapeutic response is recommended in such polypharmacy cases.
Further research is warranted to elucidate the mechanisms and clinical significance of this drug interaction.